Clinical Trial: A Live Recombinant Newcastle Disease Virus-vectored COVID-19 Vaccine Phase 1 Study

Press/Media

Period7 Jan 2022

Media coverage

2

Media coverage

  • TitleClinical Trial: A Live Recombinant Newcastle Disease Virus-vectored COVID-19 Vaccine Phase 1 Study
    Media name/outletUS Fed News
    Country/TerritoryUnited States
    Date7/01/22
    PersonsSean Liu
  • TitleClinical Trial: A Live Recombinant Newcastle Disease Virus-vectored COVID-19 Vaccine Phase 1 Study
    Media name/outletHealth Daily Digest (Ht Media)
    Country/TerritoryIndia
    Date7/01/22
    PersonsSean Liu